ATC code N04

ATC code N04 Anti-parkinson drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup N04 is part of the anatomical group N Nervous system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN04.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

N04A Anticholinergic agents

N04AA Tertiary amines

N04AA01 Trihexyphenidyl
N04AA02 Biperiden
N04AA03 Metixene
N04AA04 Procyclidine
N04AA05 Profenamine
N04AA08 Dexetimide
N04AA09 Phenglutarimide
N04AA10 Mazaticol
N04AA11 Bornaprine
N04AA12 Tropatepine

N04AB Ethers chemically close to antihistamines

N04AB01 Etanautine
N04AB02 Orphenadrine (chloride)

N04AC Ethers of tropine or tropine derivatives

N04AC01 Benzatropine
N04AC30 Etybenzatropine

N04B Dopaminergic agents

N04BA Dopa and dopa derivatives

N04BA01 Levodopa
N04BA02 Levodopa and decarboxylase inhibitor
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor
N04BA04 Melevodopa
N04BA05 Melevodopa and decarboxylase inhibitor
N04BA06 Etilevodopa and decarboxylase inhibitor
N04BA07 Foslevodopa and decarboxylase inhibitor

N04BB Adamantane derivatives

N04BB01 Amantadine

N04BC Dopamine agonists

N04BC01 Bromocriptine
N04BC02 Pergolide
N04BC03 Dihydroergocryptine mesylate
N04BC04 Ropinirole
N04BC05 Pramipexole
N04BC06 Cabergoline
N04BC07 Apomorphine
N04BC08 Piribedil
N04BC09 Rotigotine

N04BD Monoamine oxidase B inhibitors

N04BD01 Selegiline
N04BD02 Rasagiline
N04BD03 Safinamide

N04BX Other dopaminergic agents

N04BX01 Tolcapone
N04BX02 Entacapone
N04BX03 Budipine
N04BX04 Opicapone

N04C Other antiparkinson drugs

N04CX Other antiparkinson drugs

N04CX01 Istradefylline

References

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code N04". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QN04". WHO Collaborating Centre for Drug Statistics Methodology.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.